Irit Avivi

Researcher Next ID · RN-042154

Researcher · Medicine

Tel Aviv Sourasky Medical Center

Tel Aviv, Israel

Accepting doctoral researchersFunding unknown

Works count: 490
Citation count: 18,264
H-index: 58
i10-index: 184

Research interests

Medicine

Multiple Myeloma Research and Treatments

Lymphoma Diagnosis and Treatment

CAR-T cell therapy research

Chronic Lymphocytic Leukemia Research

Acute Myeloid Leukemia Research

Publications

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2303379
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01232-w
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Blood · 2021 · https://doi.org/10.1182/blood.2021011568
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(19)30110-3
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(18)30217-5
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(19)30110-3
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30685-5
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0269-2
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1707447
18 F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
Journal of Nuclear Medicine · 2009 · https://doi.org/10.2967/jnumed.109.067892

Current projects

No projects listed.